International patent registration of the real-time tissue impedance measurement–based cancer treatment system by Persian Tarava
Since its founding, Persian Tarava has led Iran’s efforts to localize cutting-edge cancer therapies by becoming the country’s first and only manufacturer of electroporation devices. Backed by R&D expertise dating to 2006, our team has successfully treated superficial, deep, even intracranial tumors using our systems.
We’re proud to hold an international patent WO2025037132 for our “Real-Time Tissue Impedance Measurement-based Cancer Treatment System,” registered through WIPO. This innovation continuously monitors tissue impedance during pulse delivery, instantly distinguishing tumors from healthy tissue to trigger therapy only where needed.
Why this matters:
- Precision therapy: Real-time feedback ensures pulses are applied exclusively to malignant tissue, sparing normal cells.
- Enhanced efficacy: Dynamic adjustment of electrical parameters boosts drug uptake into cancer cells.
- Improved safety: Continuous monitoring lets physicians fine-tune treatment promptly, reducing side effects.
International patents underscore our global ambitions and protect our intellectual property against unauthorized copying. Unlike many overseas systems with limited or no real-time control, Persian Tarava’s solution offers accurate, instantaneous impedance monitoring, delivering superior accuracy while remaining cost-competitive thanks to entirely domestic design and production.
Clinical & Research Applications:
- Non-resectable liver tumors
- Head and neck cancers
- Pancreatic and prostate malignancies
- Superficial lesions such as melanoma
- Veterinary oncology and biological research
Developed through close collaboration among biomedical engineers, oncologists, and electronics specialists, this platform is now entering broader clinical trials in Iran. Next steps include regional commercialization, a portable device version, and AI-driven treatment optimization.
With our landmark real-time impedance system, Persian Tarava is charting a new course for advanced, accessible cancer care in Iran and beyond.
